Keyphrases
Hypertension
100%
Baboon
91%
Noradrenaline
66%
Blood Pressure
64%
Hypertension Management
59%
Hypertensive Patients
58%
Blood Flow
54%
Angiotensin-converting Enzyme Inhibitor (ACEi)
43%
Fever
42%
Angiotensin II (Ang II)
39%
Vascular Smooth muscle Cells
33%
Propranolol
32%
Coronary Artery Disease
32%
Heart Rate
32%
Essential Hypertension
30%
Conscious Rabbits
30%
Hypertensive
29%
Antihypertensive Drugs
29%
Cerebrovascular Reactivity
29%
Vasodilator
28%
Beta-blockers
28%
Diastolic Blood Pressure
27%
Pyrogen
27%
Adrenoceptors
26%
Hypothalamus
26%
Vascular Hypertrophy
25%
Cholesterol
23%
Systolic Blood Pressure
23%
Thiazide Diuretics
22%
Cyclic Adenosine Monophosphate (cAMP)
22%
5-hydroxytryptamine
21%
Prostaglandins
21%
Diuretics
21%
Renin-angiotensin System
19%
Myocardial Infarction
19%
Left Ventricular Function
18%
Cerebral Blood Flow
18%
Blood Pressure Lowering
18%
Spontaneously Hypertensive Rats
18%
Vasoconstriction
18%
Moderate to Severe
17%
Estimated Glomerular Filtration Rate
17%
Placebo
17%
Confidence Interval
17%
Renal Blood Flow
17%
Type 2 Diabetes Mellitus (T2DM)
17%
Super-elderly
16%
Alzheimer's Disease
15%
Vascular Function
15%
Myocardial Contraction
15%
Pharmacology, Toxicology and Pharmaceutical Science
Noradrenalin
75%
Dipeptidyl Carboxypeptidase Inhibitor
51%
Leporidae
45%
Antihypertensive Agent
42%
Adrenergic Receptor
37%
Coronary Artery Disease
34%
Heart Infarction
31%
Propranolol
30%
Thiazide Diuretic Agent
28%
Placebo
27%
Angiotensin II
27%
Cerebrovascular Accident
26%
Congestive Heart Failure
24%
Essential Hypertension
24%
Renin
23%
Clinical Trial
23%
Angiotensin
20%
Ischemic Heart Disease
19%
Diuretic Agent
19%
Calcium Channel Blocker
18%
Side Effect
18%
Disease
18%
Cardiovascular Disease
18%
Receptor
17%
Chronic Kidney Failure
17%
Angiotensin Receptor Antagonist
17%
Indoramin
16%
Vasodilator Agent
16%
Alzheimer's Disease
15%
Creatinine
15%
Beta Adrenergic Receptor Blocking Agent
15%
Kidney Disease
15%
Cyclic AMP
14%
Antihypertensive Therapy
14%
Verapamil
14%
Adenosine
14%
Hypertensive Factor
13%
Cardiovascular Risk
13%
Hypotension
13%
Hyperplasia
13%
Isoprenaline
11%
Albuminuria
11%
Captopril
11%
Heart Left Ventricle Hypertrophy
11%
Non Insulin Dependent Diabetes Mellitus
11%
Tachycardia
11%
Methyldopa
11%
Adverse Event
10%
Tyramine
10%
Sotalol
10%
Medicine and Dentistry
Blood Pressure
74%
ACE Inhibitor
30%
Coronary Artery Disease
27%
Noradrenalin
27%
Artery
27%
Angiotensin II
26%
Systolic Blood Pressure
22%
Congestive Heart Failure
22%
Apoplexy
21%
Blood Flow
19%
Calcium Channel Blocking Agent
18%
Disease
17%
Renin Angiotensin Aldosterone System
17%
Myocardial Infarction
16%
Antihypertensive Agent
16%
Indoramin
15%
Vascular Smooth Muscle
15%
Clinical Trial
15%
Glomerular Filtration Rate
14%
Diabetes
14%
Cardiovascular System
14%
Chronic Kidney Disease
13%
Nephropathy
13%
Placebo
13%
Coronary Occlusion
13%
Hyperplasia
13%
Diastolic Blood Pressure
13%
Antihypertensive Therapy
13%
Thiazide Diuretic Agent
12%
Vascular Smooth Muscle Cell
12%
Hypotension
11%
Albuminuria
11%
Essential Hypertension
11%
Maturity Onset Diabetes of the Young
11%
Heart Muscle Blood Flow
10%
Alzheimer's Disease
10%
Sotalol
10%
Cardiology
10%
Left Ventricular Hypertrophy
10%
Blood Pressure Measurement
10%
Creatinine
9%
Cardiovascular Risk
9%
Infarction
9%
Diuretic Agent
9%
Heart Output
9%
Cell Division
8%
Propranolol
8%
Vascular Resistance
8%
Hemodynamic
8%
Angiotensin Receptor Antagonist
8%